β2-Microglobulin deficiency causes a complex immunodeficiency of the innate and adaptive immune system

被引:63
作者
Ardeniz, Omur [1 ]
Unger, Susanne [4 ,5 ]
Onay, Huseyin [2 ]
Ammann, Sandra [4 ,5 ]
Keck, Caroline [6 ]
Cianga, Corina [8 ]
Gerceker, Bengu [3 ]
Martin, Bianca [7 ]
Fuchs, Ilka [4 ,5 ]
Salzer, Ulrich [4 ,5 ]
Ikinciogullari, Aydan [9 ]
Guloglu, Deniz [9 ]
Dereli, Tugrul [3 ]
Thimme, Robert [7 ]
Ehl, Stephan [4 ,5 ]
Schwarz, Klaus [10 ,11 ]
Schmitt-Graeff, Annette [6 ]
Cianga, Petru [8 ]
Fisch, Paul [6 ]
Warnatz, Klaus [4 ,5 ]
机构
[1] Ege Univ, Fac Med, Internal Med Div Allergy & Clin Immunol, Izmir, Turkey
[2] Ege Univ, Fac Med, Dept Med Genet, Izmir, Turkey
[3] Ege Univ, Fac Med, Dept Dermatol, Izmir, Turkey
[4] Univ Med Ctr Freiburg, Ctr Chron Immunodeficiency, Freiburg, Germany
[5] Univ Freiburg, Freiburg, Germany
[6] Univ Med Ctr Freiburg, Inst Pathol, Freiburg, Germany
[7] Univ Med Ctr Freiburg, Dept Internal Med 2, Freiburg, Germany
[8] Grigore T Popa Univ Med & Pharm, Dept Immunol, Iasi, Romania
[9] Ankara Univ, Sch Med, Dept Pediat Immunol & Allergy, TR-06100 Ankara, Turkey
[10] Univ Ulm, Inst Transfus Med, D-89069 Ulm, Germany
[11] German Red Cross Blood Serv, Inst Clin Transfus Med & Immunogenet Ulm, Ulm, Germany
关键词
beta(2)-Microglobulin deficiency; human; MHC class I; hypogammaglobulinemia; neonatal Fc receptor; CD1; gamma delta T cells; CD8 T cells; CLASS-I DEFICIENCY; FAMILIAL HYPERCATABOLIC HYPOPROTEINEMIA; COMMON VARIABLE IMMUNODEFICIENCY; CYTOTOXIC T-CELLS; BETA-2-MICROGLOBULIN-DEFICIENT MICE; NK-CELLS; HLA-B; TAP DEFICIENCY; FC-RECEPTOR; MOLECULES;
D O I
10.1016/j.jaci.2014.12.1937
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Most patients with MHC class I (MHC-I) deficiency carry genetic defects in transporter associated with antigen processing 1 (TAP1) or TAP2. The clinical presentation can vary, and about half of the patients have severe skin disease. Previously, one report described beta(2)-microglobulin (beta(2)m) deficiency as another monogenetic cause of MHC-I deficiency, but no further immunologic evaluation was performed. Objective: We sought to describe the molecular and immunologic features of b2m deficiency in 2 Turkish siblings with new diagnoses. Methods: Based on clinical and serologic findings, the genetic defect was detected by means of candidate gene analysis. The immunologic characterization comprises flow cytometry, ELISA, functional assays, and immunohistochemistry. Results: Here we provide the first extensive clinical and immunologic description of beta(2)m deficiency in 2 siblings. The sister had recurrent respiratory tract infections and severe skin disease, whereas the brother was fairly asymptomatic but had bronchiectasis. Not only polymorphic MHC-I but also the related CD1a, CD1b, CD1c, and neonatal Fc receptor molecules were absent from the surfaces of beta(2)m-deficient cells. Absent neonatal Fc receptor surface expression led to low serum IgG and albumin levels in both siblings, whereas the heterozygous parents had normal results for all tested parameters except beta(2)m mRNA (B2M) expression. Similar to TAP deficiency in the absence of a regular CD8 T-cell compartment, CD8(+) gamma delta T cells were strongly expanded. Natural killer cells were normal in number but not "licensed to kill." Conclusion: The clinical presentation of patients with beta(2)m deficiency resembles that of patients with other forms of MHC-I deficiency, but because of the missing stabilizing effect of beta(2)m on other members of the MHC-I family, the immunologic defect is more extensive than in patients with TAP deficiency.
引用
收藏
页码:392 / 401
页数:10
相关论文
共 47 条
[1]   Analysis of the requirement for beta 2-microglobulin for expression and formation of human CD1 antigens [J].
Bauer, A ;
Huttinger, R ;
Staffler, G ;
Hansmann, C ;
Schmidt, W ;
Majdic, O ;
Knapp, W ;
Stockinger, H .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (06) :1366-1373
[2]  
Blumberg RS, 1998, AM J PHYSIOL-GASTR L, V274, pG227, DOI 10.1152/ajpgi.1998.274.2.G227
[3]   A prospective evaluation of degranulation assays in the rapid diagnosis of familial hemophagocytic syndromes [J].
Bryceson, Yenan T. ;
Pende, Daniela ;
Maul-Pavicic, Andrea ;
Gilmour, Kimberly C. ;
Ufheil, Heike ;
Vraetz, Thomas ;
Chiang, Samuel C. ;
Marcenaro, Stefania ;
Meazza, Raffaella ;
Bondzio, Ilka ;
Walshe, Denise ;
Janka, Gritta ;
Lehmberg, Kai ;
Beutel, Karin ;
zur Stadt, Udo ;
Binder, Nadine ;
Arico, Maurizio ;
Moretta, Lorenzo ;
Henter, Jan-Inge ;
Ehl, Stephan .
BLOOD, 2012, 119 (12) :2754-2763
[4]   Description of HLA class I- and CD8-deficient patients: Insights into the function of cytotoxic T lymphocytes and NK cells in host defense [J].
Cerundolo, Vincenzo ;
de la Salle, Henri .
SEMINARS IN IMMUNOLOGY, 2006, 18 (06) :330-336
[5]   RESTRICTION OF EPSTEIN-BARR VIRUS-SPECIFIC CYTO-TOXIC T-CELLS BY HLA-A, HLA-B, AND HLA-C MOLECULES [J].
CHEN, BP ;
LAM, V ;
KRAUS, EE ;
DEMARS, R ;
SONDEL, PM .
HUMAN IMMUNOLOGY, 1989, 26 (02) :137-147
[6]   MOST GAMMA-DELTA-T-CELLS DEVELOP NORMALLY IN BETA-2-MICROGLOBULIN-DEFICIENT MICE [J].
CORREA, I ;
BIX, M ;
LIAO, NS ;
ZIJLSTRA, M ;
JAENISCH, R ;
RAULET, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (02) :653-657
[7]   Asymptomatic deficiency in the peptide transporter associated to antigen processing (TAP) [J].
De la Salle, H ;
Saulquin, X ;
Mansour, I ;
Klaymé, S ;
Fricker, D ;
Zimmer, J ;
Cazenave, JP ;
Hanau, D ;
Bonneville, M ;
Houssaint, E ;
Lefranc, G ;
Naman, R .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2002, 128 (03) :525-531
[8]   HLA class I deficiencies due to mutations in subunit 1 of the peptide transporter TAP1 [J].
de la Salle, H ;
Zimmer, J ;
Fricker, D ;
Angenieux, C ;
Cazenave, JP ;
Okubo, H ;
Maeda, H ;
Plebani, A ;
Tongio, MM ;
Dormoy, A ;
Hanau, D .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (05) :R9-R13
[9]   HOMOZYGOUS HUMAN TAP PEPTIDE TRANSPORTER MUTATION IN HLA CLASS-I DEFICIENCY [J].
DELASALLE, H ;
HANAU, D ;
FRICKER, D ;
URLACHER, A ;
KELLY, A ;
SALAMERO, J ;
POWIS, SH ;
DONATO, L ;
BAUSINGER, H ;
LAFORET, M ;
JERAS, M ;
SPEHNER, D ;
BIEBER, T ;
FALKENRODT, A ;
CAZENAVE, JP ;
TROWSDALE, J ;
TONGIO, MM .
SCIENCE, 1994, 265 (5169) :237-241
[10]  
EPSTEIN SL, 1993, J IMMUNOL, V150, P5484